Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Summary by Ridgecrest Daily Independent - Ridgecrest, CA
Ongoing Phase II preclinical study data for Co-Dx PCR MTB and HPV tests support advancement to clinical performance testing

14 Articles

Hanford SentinelHanford Sentinel
+12 Reposted by 12 other sources
Center

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Ongoing Phase II preclinical study data for Co-Dx PCR MTB and HPV tests support advancement to clinical performance testing

Read Full Article
stocktitan.netstocktitan.net

Co-Diagnostics (Nasdaq: CODX) JV highlights TB, HPV PoC tests at VIROCON 2025

Co-Diagnostics’ JV CoSara shares preclinical data from 354 MTB and 286 HPV specimens, with Phase II work on 211 TB and 53 HPV samples supporting clinical performance testing plans in India.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Monday, December 8, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Pune icon

Pune

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal